摘要 |
Novel cephem derivatives represented by the general formula <IMG> in which the Acyl substituent is a group of the formula <IMG> wherein Ar is a lipophilic optionally substituted phenyl, naphthyl, pyridyl or benzthiazolyl group; R1 is selected from certain optionally substituted aliphatic, aromatic, arylaliphatic or sugar moieties and R2 and R3 are each independently hydrogen, alkyl or aminoalkylcarbonylamino are gram-positive antibacterial agents, especially useful in the treatment of infectious diseases caused by methicillin-resistant Staphylococcus aureus (MRSA).
|
申请人 |
BRISTOL-MYERS SQUIBB COMPANY |
发明人 |
KIM, CHOUNG U.;MISCO, PETER F., JR.;WICHTOWSKI, JOHN A.;UEDA, YASUTSUGU;HUDYMA, THOMAS W.;MATISKELLA, JOHN D.;D'ANDREA, STANLEY V.;HOEFT, SHELLEY E.;MILLER, RAYMOND F.;MANSURI, MUZAMMIL;BRONSON, JOANNE J. |